Is Alphabet or Amazon the Better Buy?
Alphabet (NASDAQ:GOOG) and Amazon (NASDAQ:AMZN) are two of the mega-cap…
Sell
27
WALD Quote, Financials, Valuation and Earnings
Last price:
$2.28
Seasonality move
:
-13.67%
Day range:
$2.26 - $2.38
52-week range:
$1.98 - $4.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.94x
P/B ratio:
0.44x
Volume:
129.7K
Avg. volume:
145.6K
1-year change:
-46.85%
Market cap:
$290.3M
Revenue:
$273.9M
EPS (TTM):
-$0.39
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
WALD
Waldencast PLC
|
$68M | -$0.09 | -- | -- | $3.98 |
|
EWCZ
European Wax Center
|
$49.7M | $0.05 | -4.6% | 75.92% | $6.71 |
|
GROV
Grove Collaborative Holdings
|
$47M | -$0.03 | -14.72% | -67.86% | $2.10 |
|
HIMS
Hims & Hers Health
|
$538.9M | $0.23 | 73.98% | 273.73% | $47.87 |
|
SKIN
The Beauty Health
|
$63.1M | -$0.07 | -18.24% | -80% | $1.76 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
WALD
Waldencast PLC
|
$2.36 | $3.98 | $290.3M | -- | $0.00 | 0% | 0.94x |
|
EWCZ
European Wax Center
|
$6.25 | $6.71 | $270.9M | 30.64x | $0.00 | 0% | 1.32x |
|
GROV
Grove Collaborative Holdings
|
$1.23 | $2.10 | $49.5M | -- | $0.00 | 0% | 0.24x |
|
HIMS
Hims & Hers Health
|
$57.56 | $47.87 | $12.9B | 83.42x | $0.00 | 0% | 7.78x |
|
SKIN
The Beauty Health
|
$1.59 | $1.76 | $200.3M | -- | $0.00 | 0% | 0.66x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
WALD
Waldencast PLC
|
20.1% | -0.252 | 29.71% | 0.53x |
|
EWCZ
European Wax Center
|
84.28% | 3.372 | 189.52% | 1.88x |
|
GROV
Grove Collaborative Holdings
|
36.37% | 3.246 | 9.48% | 0.37x |
|
HIMS
Hims & Hers Health
|
-- | 7.831 | -- | 1.18x |
|
SKIN
The Beauty Health
|
92.31% | 2.498 | 329.49% | 6.31x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
WALD
Waldencast PLC
|
-- | -- | -4.62% | -5.64% | -- | -- |
|
EWCZ
European Wax Center
|
$38.2M | $10.6M | 1.97% | 9.03% | 20.58% | $12M |
|
GROV
Grove Collaborative Holdings
|
$23.1M | -$3.5M | -49.78% | -164.34% | -7.33% | -$7.4M |
|
HIMS
Hims & Hers Health
|
$430.7M | $57.9M | 37.84% | 37.84% | 9.88% | $50.1M |
|
SKIN
The Beauty Health
|
$48.6M | -$12M | -6.09% | -66.39% | -9.64% | $1.9M |
Waldencast PLC vs. Competitors
-
Which has Higher Returns WALD or EWCZ?
European Wax Center has a net margin of -- compared to Waldencast PLC's net margin of 3.37%. Waldencast PLC's return on equity of -5.64% beat European Wax Center's return on equity of 9.03%.
Company Gross Margin Earnings Per Share Invested Capital WALDWaldencast PLC-- -- $896.6M EWCZEuropean Wax Center74.19% $0.04 $476.1M -
What do Analysts Say About WALD or EWCZ?
Waldencast PLC has a consensus price target of $3.98, signalling upside risk potential of 68.64%. On the other hand European Wax Center has an analysts' consensus of $6.71 which suggests that it could grow by 7.43%. Given that Waldencast PLC has higher upside potential than European Wax Center, analysts believe Waldencast PLC is more attractive than European Wax Center.
Company Buy Ratings Hold Ratings Sell Ratings WALDWaldencast PLC4 2 0 EWCZEuropean Wax Center3 4 1 -
Is WALD or EWCZ More Risky?
Waldencast PLC has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock WALD or EWCZ?
Waldencast PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waldencast PLC pays -- of its earnings as a dividend. European Wax Center pays out 7.54% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios WALD or EWCZ?
Waldencast PLC quarterly revenues are --, which are smaller than European Wax Center quarterly revenues of $51.4M. Waldencast PLC's net income of -- is lower than European Wax Center's net income of $1.7M. Notably, Waldencast PLC's price-to-earnings ratio is -- while European Wax Center's PE ratio is 30.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waldencast PLC is 0.94x versus 1.32x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WALDWaldencast PLC0.94x -- -- -- EWCZEuropean Wax Center1.32x 30.64x $51.4M $1.7M
-
Which has Higher Returns WALD or GROV?
Grove Collaborative Holdings has a net margin of -- compared to Waldencast PLC's net margin of -8.15%. Waldencast PLC's return on equity of -5.64% beat Grove Collaborative Holdings's return on equity of -164.34%.
Company Gross Margin Earnings Per Share Invested Capital WALDWaldencast PLC-- -- $896.6M GROVGrove Collaborative Holdings52.96% -$0.10 $20.6M -
What do Analysts Say About WALD or GROV?
Waldencast PLC has a consensus price target of $3.98, signalling upside risk potential of 68.64%. On the other hand Grove Collaborative Holdings has an analysts' consensus of $2.10 which suggests that it could grow by 70.73%. Given that Grove Collaborative Holdings has higher upside potential than Waldencast PLC, analysts believe Grove Collaborative Holdings is more attractive than Waldencast PLC.
Company Buy Ratings Hold Ratings Sell Ratings WALDWaldencast PLC4 2 0 GROVGrove Collaborative Holdings1 1 0 -
Is WALD or GROV More Risky?
Waldencast PLC has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Grove Collaborative Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock WALD or GROV?
Waldencast PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grove Collaborative Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waldencast PLC pays -- of its earnings as a dividend. Grove Collaborative Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WALD or GROV?
Waldencast PLC quarterly revenues are --, which are smaller than Grove Collaborative Holdings quarterly revenues of $43.5M. Waldencast PLC's net income of -- is lower than Grove Collaborative Holdings's net income of -$3.5M. Notably, Waldencast PLC's price-to-earnings ratio is -- while Grove Collaborative Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waldencast PLC is 0.94x versus 0.24x for Grove Collaborative Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WALDWaldencast PLC0.94x -- -- -- GROVGrove Collaborative Holdings0.24x -- $43.5M -$3.5M
-
Which has Higher Returns WALD or HIMS?
Hims & Hers Health has a net margin of -- compared to Waldencast PLC's net margin of 8.44%. Waldencast PLC's return on equity of -5.64% beat Hims & Hers Health's return on equity of 37.84%.
Company Gross Margin Earnings Per Share Invested Capital WALDWaldencast PLC-- -- $896.6M HIMSHims & Hers Health73.5% $0.20 $549.3M -
What do Analysts Say About WALD or HIMS?
Waldencast PLC has a consensus price target of $3.98, signalling upside risk potential of 68.64%. On the other hand Hims & Hers Health has an analysts' consensus of $47.87 which suggests that it could fall by -16.83%. Given that Waldencast PLC has higher upside potential than Hims & Hers Health, analysts believe Waldencast PLC is more attractive than Hims & Hers Health.
Company Buy Ratings Hold Ratings Sell Ratings WALDWaldencast PLC4 2 0 HIMSHims & Hers Health4 6 1 -
Is WALD or HIMS More Risky?
Waldencast PLC has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Hims & Hers Health has a beta of 2.094, suggesting its more volatile than the S&P 500 by 109.43%.
-
Which is a Better Dividend Stock WALD or HIMS?
Waldencast PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hims & Hers Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waldencast PLC pays -- of its earnings as a dividend. Hims & Hers Health pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WALD or HIMS?
Waldencast PLC quarterly revenues are --, which are smaller than Hims & Hers Health quarterly revenues of $586M. Waldencast PLC's net income of -- is lower than Hims & Hers Health's net income of $49.5M. Notably, Waldencast PLC's price-to-earnings ratio is -- while Hims & Hers Health's PE ratio is 83.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waldencast PLC is 0.94x versus 7.78x for Hims & Hers Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WALDWaldencast PLC0.94x -- -- -- HIMSHims & Hers Health7.78x 83.42x $586M $49.5M
-
Which has Higher Returns WALD or SKIN?
The Beauty Health has a net margin of -- compared to Waldencast PLC's net margin of -14.51%. Waldencast PLC's return on equity of -5.64% beat The Beauty Health's return on equity of -66.39%.
Company Gross Margin Earnings Per Share Invested Capital WALDWaldencast PLC-- -- $896.6M SKINThe Beauty Health69.82% -$0.08 $599M -
What do Analysts Say About WALD or SKIN?
Waldencast PLC has a consensus price target of $3.98, signalling upside risk potential of 68.64%. On the other hand The Beauty Health has an analysts' consensus of $1.76 which suggests that it could grow by 10.69%. Given that Waldencast PLC has higher upside potential than The Beauty Health, analysts believe Waldencast PLC is more attractive than The Beauty Health.
Company Buy Ratings Hold Ratings Sell Ratings WALDWaldencast PLC4 2 0 SKINThe Beauty Health0 7 0 -
Is WALD or SKIN More Risky?
Waldencast PLC has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock WALD or SKIN?
Waldencast PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waldencast PLC pays -- of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WALD or SKIN?
Waldencast PLC quarterly revenues are --, which are smaller than The Beauty Health quarterly revenues of $69.6M. Waldencast PLC's net income of -- is lower than The Beauty Health's net income of -$10.1M. Notably, Waldencast PLC's price-to-earnings ratio is -- while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waldencast PLC is 0.94x versus 0.66x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WALDWaldencast PLC0.94x -- -- -- SKINThe Beauty Health0.66x -- $69.6M -$10.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Ken Griffin Buy Sweetgreen Stock?
In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…
Where Will Planet Labs’ Stock Go Next?
On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
73
OKLO alert for Jun 12
Oklo [OKLO] is down 5.6% over the past day.
Buy
87
SMR alert for Jun 12
NuScale Power [SMR] is down 2.96% over the past day.
Buy
53
PLAY alert for Jun 12
Dave & Buster's Entertainment [PLAY] is up 0.69% over the past day.
